FORMER GM EXECUTIVE ELECTED TO AMA BOARD OF TRUSTEES

ATLANTA (November 16, 2015) -- Kevin W. Williams, a former senior executive at General Motors (GM) from Nashville, Tenn., was elected today to the American Medical Association (AMA) Board of Trustees at the organization’s Interim Meeting. Williams is the fourth person to ever to hold the public member position on the governing board of the nation’s largest and most prominent physician organization.

Williams has extensive senior leadership experience developed during a 31-year career at GM where he held numerous global roles. Most recently he served as board chairman, president and managing director of GM of Canada. He has also served as president and managing director of GM de Mexico and GM North American vice president of quality. Williams served as a member of the GM North American Strategy Board from 2003 to 2009. Prior assignments include positions as global executive director, supplier quality, development and supplier diversity for worldwide purchasing, and executive director, supplier quality and development for GM Europe, with responsibilities spanning 22 countries and 1,500 employees.

“Mr. Williams brings a wealth of knowledge and skills to the AMA board from his private sector career as high-level leader with national and international business experience,” said AMA Board Chair Stephen R. Permut, M.D. “We look forward to his new perspectives that will help enrich our continuing efforts to address the leading health care issues facing our nation.”

Williams has a demonstrated passion for giving back. He is a board member of the United Negro College Fund Foundation and Tennessee State University Foundation. He was also a trustee of Genesys Health System of Michigan.

A graduate of Tennessee State University, Williams earned a master’s degree in business administration from Central Michigan University. He later completed the GM Senior Executive Development Program.

The AMA first added a public member to its Board of Trustees in 2002. Williams will begin his four-year term at the conclusion of the AMA Annual Meeting in June 2016. He replaces Julie K. Goonewardene, who has served on the board since 2012.